- Home
- YRD vs TYRA Comparison
YRD vs TYRA Comparison
Compare YRD & TYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YRD
- TYRA
- Stock Information
- Founded
- YRD 2012
- TYRA 2018
- Country
- YRD China
- TYRA United States
- Employees
- YRD N/A
- TYRA N/A
- Industry
- YRD Finance: Consumer Services
- TYRA Biotechnology: Pharmaceutical Preparations
- Sector
- YRD Finance
- TYRA Health Care
- Exchange
- YRD Nasdaq
- TYRA Nasdaq
- Market Cap
- YRD 532.3M
- TYRA 571.9M
- IPO Year
- YRD 2015
- TYRA 2021
- Fundamental
- Price
- YRD $5.73
- TYRA $12.65
- Analyst Decision
- YRD
- TYRA Strong Buy
- Analyst Count
- YRD 0
- TYRA 8
- Target Price
- YRD N/A
- TYRA $31.00
- AVG Volume (30 Days)
- YRD 88.0K
- TYRA 231.5K
- Earning Date
- YRD 08-21-2025
- TYRA 11-06-2025
- Dividend Yield
- YRD 7.68%
- TYRA N/A
- EPS Growth
- YRD N/A
- TYRA N/A
- EPS
- YRD 2.07
- TYRA N/A
- Revenue
- YRD $856,794,857.00
- TYRA N/A
- Revenue This Year
- YRD N/A
- TYRA N/A
- Revenue Next Year
- YRD N/A
- TYRA N/A
- P/E Ratio
- YRD $2.76
- TYRA N/A
- Revenue Growth
- YRD 12.42
- TYRA N/A
- 52 Week Low
- YRD $4.37
- TYRA $6.42
- 52 Week High
- YRD $9.20
- TYRA $29.60
- Technical
- Relative Strength Index (RSI)
- YRD 41.97
- TYRA 62.48
- Support Level
- YRD $5.71
- TYRA $11.89
- Resistance Level
- YRD $6.35
- TYRA $13.24
- Average True Range (ATR)
- YRD 0.18
- TYRA 0.79
- MACD
- YRD -0.02
- TYRA 0.07
- Stochastic Oscillator
- YRD 4.38
- TYRA 82.01
About YRD Yiren Digital Ltd.
Yiren Digital Ltd is an AI-powered platform providing a comprehensive suite of financial and lifestyle services in China. Its mission is to elevate customers' financial well-being and enhance their quality of life by delivering digital financial services, tailor-made insurance solutions, and premium lifestyle services. The company supports clients at various growth stages, addressing financing needs arising from consumption and production activities, while aiming to augment the overall well-being and security of individuals, families, and businesses.
About TYRA Tyra Biosciences Inc.
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.